SUSQUEHANNA INTERNATIONAL GROUP, LLP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$4,270,010
-9.8%
47,667
-14.2%
0.00%
Q2 2023$4,732,166
+22.2%
55,581
+18.8%
0.00%
Q1 2023$3,872,121
+42.1%
46,793
+35.0%
0.00%
Q4 2022$2,725,773
-68.8%
34,657
-70.6%
0.00%
-100.0%
Q3 2022$8,726,000
+274.5%
117,864
+229.8%
0.00%
Q2 2022$2,330,000
-22.9%
35,736
-25.2%
0.00%
Q1 2022$3,022,000
-51.6%
47,797
-59.4%
0.00%
Q4 2021$6,240,000
-47.3%
117,662
-29.8%
0.00%
-100.0%
Q3 2021$11,834,000
-17.5%
167,630
-22.2%
0.00%
-66.7%
Q2 2021$14,351,000
+271.5%
215,338
+518.8%
0.00%
Q1 2021$3,863,000
-55.9%
34,800
-52.8%
0.00%
Q4 2020$8,756,000
+23.3%
73,724
-9.4%
0.00%
-100.0%
Q3 2020$7,102,000
+13.3%
81,402
+16.3%
0.00%0.0%
Q2 2020$6,266,000
-51.4%
69,969
-45.9%
0.00%
-75.0%
Q1 2020$12,884,000
+418.5%
129,278
+497.8%
0.00%
Q4 2019$2,485,000
-72.1%
21,624
-69.4%
0.00%
-100.0%
Q3 2019$8,913,000
-14.5%
70,660
-18.4%
0.00%
+200.0%
Q2 2019$10,422,000
+705.4%
86,630
+485.3%
0.00%
Q1 2019$1,294,000
+23.8%
14,800
+41.6%
0.00%
Q4 2018$1,045,000
-26.4%
10,449
-15.7%
0.00%
Q3 2018$1,420,000
-51.0%
12,400
-61.6%
0.00%
-100.0%
Q2 2018$2,898,000
+483.1%
32,310
+375.1%
0.00%
Q1 2018$497,000
-12.3%
6,800
-30.3%
0.00%
Q4 2017$567,000
+27.4%
9,759
-13.3%
0.00%
Q2 2017$445,000
-86.0%
11,260
-85.7%
0.00%
-100.0%
Q4 2016$3,169,000
+605.8%
78,842
+535.8%
0.00%
Q3 2016$449,000
+80.3%
12,400
+44.2%
0.00%
Q2 2016$249,000
+16.4%
8,600
+29.5%
0.00%
Q4 2015$214,000
-28.9%
6,642
-28.6%
0.00%
Q3 2015$301,000
-86.0%
9,306
-82.1%
0.00%
-100.0%
Q2 2015$2,151,000
+41.6%
51,995
+53.8%
0.00%0.0%
Q1 2015$1,519,000
+60.7%
33,816
+33.8%
0.00%
Q4 2014$945,000
+7.1%
25,278
+1.1%
0.00%
Q2 2014$882,000
-44.1%
24,992
-48.3%
0.00%
Q1 2014$1,577,000
+91.4%
48,385
+147.5%
0.00%
Q4 2013$824,000
+266.2%
19,550
+246.1%
0.00%
Q3 2013$225,0005,6490.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders